Showing results (961-970 of 1,209) with videos related to

Sort By:
Pageof 121
Antiviral Therapy|September 17, 2013
Changes in biomarkers of liver disease during successful combination antiretroviral therapy in HIV-HCV-coinfected individualsJanine Rohrbach, Felix Stickel, Patrick Schmid, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2020
The Role of Human Immunodeficiency Virus (HIV) Asymptomatic Status When Starting Antiretroviral Therapy on Adherence and Treatment Outcomes and Implications for Test and Treat: The Swiss HIV Cohort StudyTracy R Glass, Huldrych F Günthard, Alexandra Calmy, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 12, 2021
Rate of treatment success and associated factors in the program for drug-susceptible tuberculosis in the Forest Region, Republic of Guinea, 2010-2017: A real-world retrospective observational cohort studyValérie Schoenbaechler, Yakpazouo Guilavogui, Sosso Onivogui, et al.
Journal of the International AIDS Society|November 14, 2014
AIDS defining opportunistic infections in patients with high CD4 counts in the combination antiretroviral therapy (cART) era: things ain't what they used to beValentin Gisler, David Kraus, Johannes Nemeth, et al.
International Journal for Parasitology. Drugs and Drug Resistance|May 4, 2024
In vitro and in vivo activities of a trithiolato-diRuthenium complex conjugated with sulfadoxine against the apicomplexan parasite Toxoplasma gondiiGhalia Boubaker, Alice Bernal, Anitha Vigneswaran, et al.
The Journal of Infectious Diseases|February 4, 2011
Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort studyRubin Lubomirov, Sara Colombo, Julia di Iulio, et al.
Clinical Pharmacology and Therapeutics|January 20, 2007
Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individualsM Rotger, H Tegude, S Colombo, et al.
Lancet (London, England)|September 19, 2003
Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general populationChristian Jaggy, Jan von Overbeck, Bruno Ledergerber, et al.
The Journal of Infectious Diseases|March 20, 2020
Changes in Renal Function After Switching From TDF to TAF in HIV-Infected Individuals: A Prospective Cohort StudyBernard Surial, Bruno Ledergerber, Alexandra Calmy, et al.
Journal of Clinical Immunology|October 31, 2002
Cytotoxic HIV-1 p55gag-specific CD4+ T cells produce HIV-inhibitory cytokines and chemokinesBarbara Lotti, Thomas Wendland, Hansjakob Furrer, et al.
Pageof 121